Envista Holdings Co. (NYSE:NVST) Position Increased by Paradice Investment Management LLC

Paradice Investment Management LLC grew its stake in shares of Envista Holdings Co. (NYSE:NVST) by 3.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,652,332 shares of the company’s stock after purchasing an additional 61,139 shares during the quarter. Envista makes up 6.3% of Paradice Investment Management LLC’s portfolio, making the stock its 5th largest holding. Paradice Investment Management LLC owned about 0.96% of Envista worth $31,873,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently made changes to their positions in NVST. Creative Planning lifted its position in shares of Envista by 30.2% during the 3rd quarter. Creative Planning now owns 31,575 shares of the company’s stock valued at $624,000 after acquiring an additional 7,329 shares during the last quarter. Blue Trust Inc. boosted its holdings in Envista by 69.7% in the third quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock worth $39,000 after purchasing an additional 804 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its holdings in Envista by 50.8% in the third quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock worth $43,000 after purchasing an additional 728 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new stake in Envista in the third quarter worth $31,000. Finally, Wealth Enhancement Advisory Services LLC boosted its holdings in Envista by 11.2% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 15,314 shares of the company’s stock worth $303,000 after purchasing an additional 1,538 shares in the last quarter.

Envista Stock Performance

Shares of NYSE:NVST opened at $21.59 on Tuesday. The company has a quick ratio of 1.77, a current ratio of 2.04 and a debt-to-equity ratio of 0.44. Envista Holdings Co. has a 12 month low of $15.15 and a 12 month high of $23.06. The company has a 50 day moving average of $19.99 and a 200 day moving average of $19.39.

Envista (NYSE:NVST) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.24 EPS for the quarter, beating the consensus estimate of $0.23 by $0.01. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. On average, sell-side analysts expect that Envista Holdings Co. will post 1.06 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. Leerink Partnrs upgraded shares of Envista from a “strong sell” rating to a “hold” rating in a report on Thursday, October 31st. Leerink Partners upgraded shares of Envista from an “underperform” rating to a “market perform” rating and increased their target price for the company from $16.00 to $23.00 in a research note on Thursday, October 31st. Wells Fargo & Company increased their price target on shares of Envista from $20.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 6th. Needham & Company LLC reissued a “hold” rating on shares of Envista in a report on Thursday, February 6th. Finally, Stifel Nicolaus raised their price objective on shares of Envista from $18.00 to $21.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, Envista currently has an average rating of “Hold” and an average price target of $20.21.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.